A multi-country outbreak of mpox has been ongoing, as detailed in the latest situation report released on April 30, 2024. This report marks the 32nd update on the epidemiology of the outbreak, highlighting significant developments and key recommendations.

One of the major updates included in the report is the revision of WHO SAGE recommendations on mpox vaccines in outbreak settings. This revision aims to enhance the effectiveness of vaccination strategies in controlling the spread of the disease.

Furthermore, forthcoming revisions to the interim guidance on Diagnostic testing for the monkeypox virus (MPXV) were also mentioned in the report. These revisions are expected to improve diagnostic capabilities and streamline testing procedures for better disease management.

The report also shed light on a recent high-level emergency regional meeting on mpox held in the Democratic Republic of the Congo (DRC). The meeting, organized by WHO and Africa CDC in collaboration with the Ministry of Public Health, Hygiene, and Prevention, emphasized the importance of enhanced surveillance, precise diagnostics, and international cooperation in addressing the mpox public health challenge.

The efforts highlighted in the report underscore the critical need for a coordinated and proactive approach to combatting the spread of mpox. With a focus on surveillance, diagnostics, and collaboration, stakeholders are working together to mitigate the impact of the outbreak and protect public health.